Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 7.59% is 289% above its 5-year average of -4.01%, around the middle of its 5-year range (-97.88%–59.13%).
9.12% below its 12-month average of 8.35%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 12.29%.
OPERATING MARGIN
7.59%
OPERATING MARGIN AVG TTM
8.35%
OPERATING MARGIN AVG 3Y
9.02%
OPERATING MARGIN AVG 5Y
-4.01%
OPERATING MARGIN AVG 10Y
-49.57%
OPERATING MARGIN AVG 15Y
-312.53%
OPERATING MARGIN AVG 20Y
-408.34%
CURRENT VS TTM AVG
-9.12%
CURRENT VS 3Y AVG
-15.85%
CURRENT VS 5Y AVG
+289.15%
CURRENT VS 10Y AVG
+115.31%
CURRENT VS 15Y AVG
+102.43%
CURRENT VS 20Y AVG
+101.86%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 636 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Acadia Pharmaceuticals Inc.
Market Cap
$3.43B
Operating Margin
7.59%
TTM Avg
8.35%
3Y Avg
9.02%
5Y Avg
-4.01%
Market Cap
$3.50B
Operating Margin
-1.17%
TTM Avg
-12.22%
3Y Avg
-19.38%
5Y Avg
-20.83%
Market Cap
$3.54B
Operating Margin
-72.84%
TTM Avg
-2371.95%
3Y Avg
-1360.37%
5Y Avg
-967.05%
Market Cap
$3.09B
Operating Margin
-3.25%
TTM Avg
-34.29%
3Y Avg
-2164.03%
5Y Avg
-1442.69%
Market Cap
$3.08B
Operating Margin
0.00%
TTM Avg
-180.11%
3Y Avg
-313.94%
5Y Avg
-1209.42%
Market Cap
$3.08B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-93.42%
5Y Avg
-160.46%
Market Cap
$3.02B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc. (ACAD) | $3.43B | 7.59% | 8.35% | 9.02% | -4.01% |
| CareDx, Inc (CDNA)vs › | $3.44B | -0.92% | 2.81% | -22.73% | -18.78% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.50B | -1.17% | -12.22% | -19.38% | -20.83% |
| Celcuity Inc. (CELC)vs › | $3.54B | 0.00% | 0.00% | 0.00% | 0.00% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.54B | -72.84% | -2371.95% | -1360.37% | -967.05% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.09B | -3.25% | -34.29% | -2164.03% | -1442.69% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.08B | 0.00% | -180.11% | -313.94% | -1209.42% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.08B | 0.00% | 0.00% | -93.42% | -160.46% |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.02B | 0.00% | 0.00% | 0.00% | 0.00% |
| ICU Medical, Inc. (ICUI)vs › | $3.97B | 5.04% | 3.30% | 1.43% | 3.80% |
Gross Margin
91.1%
Operating Margin
7.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 12.29% |
| 2026-03-31 | -1.72% |
| 2025-12-31 | 6.12% |
| 2025-09-30 | 12.83% |
| 2025-06-30 | 12.24% |
| 2025-03-31 | 7.90% |
| 2024-12-31 | 59.13% |
| 2024-09-30 | 12.64% |
| 2024-06-30 | 12.58% |
| 2024-03-31 | 7.39% |
| 2023-12-31 | 15.12% |
| 2023-09-30 | -27.29% |
| 2023-06-30 | 1.84% |
| 2023-03-31 | -45.23% |
| 2022-12-31 | -33.75% |
| 2022-09-30 | -23.61% |
| 2022-06-30 | -25.01% |
| 2022-03-31 | -97.88% |
| 2021-12-31 | -34.15% |
| 2021-09-30 | -11.63% |
| 2021-06-30 | -37.93% |
| 2021-03-31 | -62.66% |
| 2020-12-31 | -55.50% |
| 2020-09-30 | -71.24% |
| 2020-06-30 | -39.97% |
| 2020-03-31 | -99.39% |
| 2019-12-31 | -57.36% |
| 2019-09-30 | -48.02% |
| 2019-06-30 | -68.61% |
| 2019-03-31 | -139.19% |
| 2018-12-31 | -112.93% |
| 2018-09-30 | -105.09% |
| 2018-06-30 | -112.30% |
| 2018-03-31 | -112.18% |
| 2017-12-31 | -160.71% |
| 2017-09-30 | -186.38% |
| 2017-06-30 | -224.56% |
| 2017-03-31 | -580.96% |
| 2016-12-31 | -654.00% |
| 2016-09-30 | -1374.32% |
| 2016-06-30 | -74147.42% |
| 2016-03-31 | -1256550.00% |
| 2015-12-31 | -268029.41% |
| 2015-09-30 | -99994.87% |
| 2015-06-30 | -3949700.00% |
| 2015-03-31 | -1013800.00% |
| 2014-12-31 | -60755.32% |
| 2014-09-30 | -166626.67% |
| 2014-06-30 | -77582.14% |
| 2014-03-31 | -59860.00% |
| 2013-12-31 | -32875.68% |
| 2013-09-30 | -4504.58% |
| 2013-06-30 | -2030.38% |
| 2013-03-31 | -1478.18% |
| 2012-12-31 | -1794.47% |
| 2012-09-30 | -69.21% |
| 2012-06-30 | -906.34% |
| 2012-03-31 | -1384.67% |
| 2011-12-31 | -903.74% |
| 2011-09-30 | -872.09% |
| 2011-06-30 | -1431.30% |
| 2011-03-31 | -1347.36% |
| 2010-12-31 | 82.28% |
| 2010-09-30 | -184.35% |
| 2010-06-30 | -187.03% |
| 2010-03-31 | -257.67% |
| 2009-12-31 | -492.14% |
| 2009-09-30 | -360.33% |
| 2009-06-30 | -704.45% |
| 2009-03-31 | -4055.61% |
| 2008-12-31 | -4372.62% |
| 2008-09-30 | -5705.32% |
| 2008-06-30 | -10758.76% |
| 2008-03-31 | -2287.97% |
| 2007-12-31 | -1181.62% |
| 2007-09-30 | -914.31% |
| 2007-06-30 | -613.28% |
| 2007-03-31 | -686.38% |
| 2006-12-31 | -764.24% |
| 2006-09-30 | -645.34% |
| 2006-06-30 | -683.89% |
| 2006-03-31 | -398.11% |
| 2005-12-31 | -437.98% |
| 2005-09-30 | -348.78% |
| 2005-06-30 | -258.24% |
| 2005-03-31 | -249.45% |
| 2004-12-31 | -688.15% |
| 2004-09-30 | -399.83% |
| 2004-06-30 | -579.43% |
| 2004-03-31 | -696.18% |
| 2003-12-31 | -1044.88% |
| 2003-09-30 | 100.00% |
| 2003-06-30 | -127.29% |
| 2003-03-31 | -175.84% |
